As the coronavirus first started to spread across the globe last March, Yale experts came together to build a biorepository — or library — of COVID-19 patient samples. Their goal was to provide researchers across the University with access to the human material needed to unveil the mysteries of what, at the time, was an unfamiliar virus.
The team of experts decided to call themselves Yale IMPACT, which stands for “implementing public health action against coronavirus CT.” Yale IMPACT conveys the weight of biomedical research in an unprecedented pandemic and represents a partnership between the School of Medicine, School of Public Health, and the Yale-New Haven Hospital. The team is led by YSPH department chair of epidemiology Albert Ko and Director of the Yale Institute of Global Health Saad Omer.
The project aims to respond to demands for COVID-19 biosamples — the team works with the community and YNHH to consolidate a robust bank of material for scientists to access for research.
Click here to read more.